Use of Tissue Type Plasminogen Activator in Sickle Cell Disease Patients Experiencing Stroke
source: pixabay.com

Use of Tissue Type Plasminogen Activator in Sickle Cell Disease Patients Experiencing Stroke

by Lauren Taylor from In The Cloud Copy Sickle cell disease or SCD is a type of red blood cell disorder in which the normally round red blood cells are…

Continue Reading Use of Tissue Type Plasminogen Activator in Sickle Cell Disease Patients Experiencing Stroke
Experimental Treatment for Sickle Cell Disease Earns Orphan Drug Designation in the EU
source: pixabay.com

Experimental Treatment for Sickle Cell Disease Earns Orphan Drug Designation in the EU

According to a story from Street Insider, the biopharmaceutical company Forma Therapeutics Holdings, Inc., recently announced that its investigational therapy candidate FT-4202 has earned Orphan Drug designation from the European…

Continue Reading Experimental Treatment for Sickle Cell Disease Earns Orphan Drug Designation in the EU
CRISPR/Cas9 Looks Promising for Transfusion Dependent Sickle Cell Disease and Beta Thalassemia Patients 
source: pixabay.com

CRISPR/Cas9 Looks Promising for Transfusion Dependent Sickle Cell Disease and Beta Thalassemia Patients 

   CRISPR/Cas9 technology reached another milestone with encouraging results in two recent trials of CTX001. An article in Pharmaceutical Technology carried an announcement by CRISPR Therapeutics and Vertex Pharmaceuticals about…

Continue Reading CRISPR/Cas9 Looks Promising for Transfusion Dependent Sickle Cell Disease and Beta Thalassemia Patients 
An Oklahoma Medical Research Foundation Scientist Played a Critical Role in Developing a New Sickle Cell Disease Treatment
source: pixabay.com

An Oklahoma Medical Research Foundation Scientist Played a Critical Role in Developing a New Sickle Cell Disease Treatment

According to a story from The Oklahoman, Dr. Roger McEver, who is a scientist and the Vice President of Research at the Oklahoma Medical Research Foundation (OMRF), played a pioneering…

Continue Reading An Oklahoma Medical Research Foundation Scientist Played a Critical Role in Developing a New Sickle Cell Disease Treatment
New Prime Editing Has The Potential to Search and Replace up to 89% of Genetic Defects
source: pixabay.com

New Prime Editing Has The Potential to Search and Replace up to 89% of Genetic Defects

  CNN recently covered a story in the publication Nature about a paper explaining base editing (or prime editing). The researchers who created the technology set forth the process of using base…

Continue Reading New Prime Editing Has The Potential to Search and Replace up to 89% of Genetic Defects

CRISPR Gene Editing Promises to Cure 10,000 diseases. Now in Its First Human Clinical Trial. Will it Eventually Deliver?

  Clustered Regularly Interspaced Short Palindromic Repeats is more commonly known as CRISPR. As reported recently in Science News, the CRISPR/Cas9 “molecular scissors” is slated to make its highly anticipated debut…

Continue Reading CRISPR Gene Editing Promises to Cure 10,000 diseases. Now in Its First Human Clinical Trial. Will it Eventually Deliver?
Antibodies: The Key to Fighting Sickle Cell Anemia? Approval Could be Just Months Away
kalhh / Pixabay

Antibodies: The Key to Fighting Sickle Cell Anemia? Approval Could be Just Months Away

According to a story from PMLive, the US Food and Drug Administration (FDA) has recently begun the priority review process for a new potential therapy from pharmaceutical behemoth Novartis. This…

Continue Reading Antibodies: The Key to Fighting Sickle Cell Anemia? Approval Could be Just Months Away

Experimental Drug for Sickle Cell Disease Earns Fast Track Designation

According to a story from BioSpace, the biopharmaceutical company Imara, Inc. has recently announced that its experimental product candidate IMR-687 has earned Fast Track designation from the US Food and…

Continue Reading Experimental Drug for Sickle Cell Disease Earns Fast Track Designation
A Beta Thalassemia Patient will be the First Dosed with CRISPR-Based Gene Therapy in Company Sponsored Trial
mcmurryjulie / Pixabay

A Beta Thalassemia Patient will be the First Dosed with CRISPR-Based Gene Therapy in Company Sponsored Trial

According to a story from MedCity News, a patient with the rare blood disorder beta thalassemia will be the first patient dosed in a Phase I/II clinical trial involving a…

Continue Reading A Beta Thalassemia Patient will be the First Dosed with CRISPR-Based Gene Therapy in Company Sponsored Trial
Chinese Researcher’s Gene Editing Project Lands Him in Hot Water, But Could it Lead to Answers for Rare Disease Patients in Future?
source: pixabay.com

Chinese Researcher’s Gene Editing Project Lands Him in Hot Water, But Could it Lead to Answers for Rare Disease Patients in Future?

One Chinese scientist has completed a research project that has shocked many in the medical community. Two twin baby girls born in November of 2018 where the recipients of his…

Continue Reading Chinese Researcher’s Gene Editing Project Lands Him in Hot Water, But Could it Lead to Answers for Rare Disease Patients in Future?
The Patriots Raise Awareness for Sickle Cell Anemia and Duchenne Muscular Dystrophy
Source: Pixabay.com

The Patriots Raise Awareness for Sickle Cell Anemia and Duchenne Muscular Dystrophy

This past Sunday, December 2nd, during the Patriot's game against the Minnesota Vikings, 20 players wore customized cleats to spread awareness for various philanthropic causes. This is the third year…

Continue Reading The Patriots Raise Awareness for Sickle Cell Anemia and Duchenne Muscular Dystrophy